Latest Asx Market Announcements News

SportsHero Limited has resumed trading on the ASX following a Supreme Court ruling addressing the company’s failure to lodge required cleansing notices for recent share issues.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Piche Resources Limited has had its trading suspension lifted immediately following the announcement of a new capital raising initiative, signaling a fresh chapter for the mining company.

Eagle Mountain Mining has requested a voluntary suspension of its ASX-listed securities pending a capital raising announcement, with trading expected to resume by 11 November 2025.

Clime Investment Management is issuing free bonus options to shareholders, offering a new opportunity to increase holdings at a fixed exercise price before mid-2026.

Polymetals Resources Ltd has had its trading suspension lifted following an announcement about a serious safety incident at its Endeavor Mine Site, raising questions about operational impacts and regulatory responses.

Global X Management (AUS) Limited has announced updated estimated distributions for three ETFs on the ASX AQUA Market for the period ending 31 October 2025, including key dates and dividend reinvestment options.

Franklin Templeton Australia has launched the Franklin Australian Absolute Return Bond Fund – Class A, an actively managed fixed income fund now available on the ASX. The fund aims to deliver returns exceeding the Bloomberg AusBond Bank Bill Index with a medium risk profile and transparent fee structure.

Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.

Platinum Asset Management has finalized its merger with L1 Capital, issuing over 1.65 billion new shares and announcing a rebrand to L1 Group Limited alongside significant board changes and share escrow arrangements.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.

Andromeda Metals has responded to ASX queries regarding its commissioned East Coast Research report, clarifying compliance with disclosure rules and differences in project assumptions.